NanoViricides Inc. (NNVC)

[changes_iv]

In Vivo Pharmacokinetic and Pharmacodynamic Studies for nanomedicines on cancer. How different are these nanomedicine studies from studies for nanoviricides in a host?

Pharmacokinetics/pharmacodynamics (PK/PD): Data collected at multiple timepoints after the administration of a nanomedicine in animal models allows for a complete pharmacokinetic and pharmacodynamic analysis of the nano agent in vivo. PK/PD assessments are performed using WinNonlin data management, a statistics, modeling, and visualization tool for PK data analysis. Parameters typically provided for a given nanomedicine include drug concentration over time, area under the curve (AUC), elimination half life, clearance, and time of maximum concentration.